SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and ...
SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new strategy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results